Antiparasitic activity of aromatic diamidines and their patented literature

Bibliography

• SOEIRO MN, DE SOUZA EM, STEPHENS CE, BOYKIN DW: Aromatic diamidines as antiparasitic agents. Expert Opin. Investig. Drugs. (2005) 14(8):957-972.
   PubMed Web of Science ®Google Scholar
• WILSON WD, NGUYEN B, TANIOUS FA et al.: Dications that target the DNA minor groove: compound design and preparation, DNA interactions, cellular distribution and biological activity. Curr. Med. Chem. Anticancer Agents (2005) 5(4):389-408.
   PubMedGoogle Scholar
• SCHOENBACH EB, GREENSPAN EM: The pharmacology, mode of action and therapeutic potentialities of stilbamidine, pentamidine, propamidine and other aromatic diamidines – a review. Medicine (Baltimore) (1948) 27:327-377.
   PubMed Web of Science ®Google Scholar
• LIONAKIS MS, LEWIS RE, SAMONIS G, KONTOYIANNIS DP: Pentamidine is active in vitro against Fusarium species. Antimicrob. Agents Chemother. (2003) 7(10):3252-3259.
   Google Scholar
• DEETZ TR, SAWYER MH, BILLMAN G, SCHUSTER FL, VISVESVARA GS: Successful treatment of Balamuthia amoebic encephalitis: presentation of 2 cases. Clin. Infect. Dis. (2003) 37(10):1304-1312.
   PubMed Web of Science ®Google Scholar
• CUSHION MT, WALZER PD, COLLINS MS et al.: Highly active anti-Pneumocystis carinii compounds in a library of novel piperazine-linked bisbenzamidines and related compounds. Antimicrob. Agents Chemother. (2004) 48:4209-4216.
   PubMed Web of Science ®Google Scholar
• MEHTA A, SHAHA C: Apoptotic death in Leishmania donovani promastigotes in response to respiratory chain inhibition: complex II inhibition results in increased pentamidine cytotoxicity. J. Biol. Chem. (2004) 279(12):11798-11813.
   PubMed Web of Science ®Google Scholar
• DE SOUZA EM, LANSIAUX A, BAILLY C et al.: Phenyl substitution of furamidine markedly potentiates its antiparasitic activity against Trypanosoma cruzi and Leishmania amazonensis. Biochem. Pharmacol. (2004) 68:593-600.
   PubMed Web of Science ®Google Scholar
• DE SOUZA EM, MELO G, DW BOYKIN et al.: Trypanocidal activity of the phenyl-substituted analogue of furamidine DB569 against T. cruzi infection in vivo. J. Antimicrob. Chemother. (2006a) 58(3):610-614.
   Google Scholar
• DE SOUZA EM, MENNA-BARRETO R, ARAÙJO-JORGE TC et al.: Antiparasitic activity of aromatic diamidines is related to apoptosis-like death in Trypanosoma cruzi. Parasitology (2006b) 133:75-79.
   PubMedGoogle Scholar
• WERBOVETZ K: Diamidines as antitrypanosomal, antileishmanial and antimalarial agents. Curr. Opin. Investig. Drugs (2006) 7(2):147-157.
   PubMed Web of Science ®Google Scholar
• DE SOUZA EM, MELO G, SOEIRO MNC et al.: Electrocardiographic findings in acutely and chronically T. cruzi-infected mice treated by a phenyl-substituted analogue of furamidine DB569. Drug Targets Insights (2007) (In Press).
   PubMedGoogle Scholar
• SILVA CF, MEUSER MB, MOTA RA et al.: Activity of ‘reversed’ diamidines against Trypanosoma cruzi “in vitro”. Biochem. Pharmacol. (2007a) 73(12):1939-1946.
   PubMedGoogle Scholar
• MACHARIA JC, BOURDICHON AJ, GICHERU MM: Efficacy of Trypan: a diminazene based drug as antileishmanial agent. Acta Trop. (2004) 92:267-272.
   PubMed Web of Science ®Google Scholar
• ROSYPAL AC, HALL JE, BAKUNOVA S et al.: In vitro activity of dicationic compounds against a North American foxhound isolate of Leishmania infantum. Rev. Parasitol. (2007) 145(3-4):207-216.
   Google Scholar
• TIDWELL RR, BOYKIN DW: Minor groove binders as antimicrobial agents. In small molecule DNA and RNA binder: synthesis to nucleic acid complexes. Wiley-VCH: New York (2003) :416-460.
   Google Scholar
• MAYENCE A, VANDEN EYNDE JJ, KROGSTAD FM, KROGSTAD DJ, CUSHION MT, HUANG TL: Parallel solution-phase synthesis of conformationally restricted congeners of pentamidine and evaluation of their antiplasmodial activities. J. Med. Chem. (2004) 47(10):2700-2705.
   PubMedGoogle Scholar
• KOCKEN CH, VAN DER WEL A, ARBE-BARNES S et al.: Plasmodium vivax: in vitro susceptibility of blood stages to synthetic trioxolane compounds and the diamidine DB75. Exp Parasitol. (2006) 113(3):197-200.
   PubMedGoogle Scholar
• LINDSAY DS, BLAGBURN BL, HALL JE, TIDWELL RR: Activity of pentamidine and pentamidine analogs against Toxoplasma gondii in cell cultures. Antimicrob. Agents Chemother. (1991) 35:1914-1916.
   PubMed Web of Science ®Google Scholar
• DENISE H, BARRETT MP: Uptake and mode of action of drugs used against sleeping sickness. Biochem. Pharmacol. (2001) 61:1-5.
   PubMed Web of Science ®Google Scholar
• JUNG S, SCHELPER RL, VISVESVARA GS, CHANG HT: Balamuthia mandrillaris meningoencephalitis in an immunocompetent patient: an unusual clinical course and a favorable outcome. Arch. Pathol. Lab. Med. (2004) 128(4):466-468.
   PubMed Web of Science ®Google Scholar
• PEREZ-SANTONJA JJ, KILVINGTON S, HUGHES R, TUFAIL A, MATHESON M, DART JK: Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity. Ophthalmology (2003) 110(8):1593-1600.
   PubMed Web of Science ®Google Scholar
• RUEBUSH TK, CONTACOS PG, STECK EA: Chemotherapy of Babesia microti infections in Mongolian Jirds. Antimicrob. Agents Chemother. (1980) 18(2):289-291.
   PubMed Web of Science ®Google Scholar
• CALONGE MM, BAYOUMI AE, CUBRIA JC, BALANA-FOUCE R, ORDONEZ D: Effects of cationic diamidines on polyamine metabolism in the trypanosomatid Crithidia fasciculata. Life Sci. (1996) 59:PL191-PL197.
   PubMedGoogle Scholar
• BLAGBURN BL, SUNDERMANN CA, LINDSAY DS, HALL JE, TIDWELL RR: Inhibition of Cryptosporidium parvum in neonatal Hsd:(ICR)BR Swiss mice by polyether ionophores and aromatic amidines. Antimicrob. Agents Chemother. (1991) 35:1520-1523.
   PubMed Web of Science ®Google Scholar
• BELL CA, CORY M, FAIRLEY TA, HALL JE, TIDWELL RR: Structure–activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity. Antimicrob. Agents Chemother. (1991) 35(6):1099-1107.
   PubMed Web of Science ®Google Scholar
• LANTERI CA, TRUMPOWER BL, TIDWELL RR, MESHNICK SR: DB75, a novel trypanocidal agent, disrupts mitochondrial function in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. (2004) 48:3968-3974.
   PubMed Web of Science ®Google Scholar
• MILETTI KE, LEIBOWITZ MJ: Pentamidine inhibition of group I intron splicing in Candida albicans correlates with growth inhibition. Antimicrob. Agents Chemother. (2000) 44(4):958-966.
   PubMed Web of Science ®Google Scholar
• LIONAKIS MS, CHAMILOS G, LEWIS RE: Pentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis. Antimicrob. Agents Chemother. (2006) 50(1):294-297.
   PubMedGoogle Scholar
• DEL POETA M, SCHELL WA, DYKSTRA CC et al.: Structure in vitro activity relationships of pentamidine analogues and dication-substituted bisbenzimidazoles as new antifungal agents. Antimicrob. Agents Chemother. (1998) 42(10):2495-2502.
   PubMed Web of Science ®Google Scholar
• AFELTRA J, MEIS JF, VITALE RG, MOUTON JW, VERWEIJ PE: In vitro activities of pentamidine pyrimethamine trimethoprim and sulfonamides against Aspergillus species. Antimicrob. Agents Chemother. (2002a) 46(6):2029-2031.
   PubMed Web of Science ®Google Scholar
• AFELTRA J, DANNAOUI E, MEIS JF, RODRIGUEZ-TUDELA JL, VERWEIJ PE: In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans. Antimicrob. Agents Chemother. (2002b) 46(10):3323-3326.
   PubMed Web of Science ®Google Scholar
• BOYKIN DW, KUMAR A, SPYCHALA J et al.: Dicationic diaryl furans as anti- Pneumocystis carinii agents. J. Med. Chem. (1995) 38:912-916.
   PubMed Web of Science ®Google Scholar
• VASCONCELLES MJ, BERNARDO MV, KING C, WELLER EA, ANTIN JH: Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections. Biol. Blood Marrow Transplant. (2000) 6(1):35-43.
   PubMed Web of Science ®Google Scholar
• BAILLY C, DASSONNEVILLE L, CARRASCO C et al.: Relationships between topoisomerase II inhibition, sequence-specificity and DNA binding mode of dicationic diphenylfuran derivatives. Anti. Cancer Drug Des. (1999) 14(1):47-60.
   Google Scholar
• LANSIAUX A, TANIOUS F, MISHAL Z et al.: Distribution of furamidine analogues in tumor cells: targeting of the nucleus or mitochondria depending on the amidine substitution. Cancer Res. (2002) 62:7219-7229.
   PubMed Web of Science ®Google Scholar
• PUCKOWSKA A, BIELAWSKI K, BIELAWSKA A, MIDURANOWACZEK K: Aromatic analogues of DNA minor groove binders-synthesis and biological evaluation. Eur. J. Med. Chem. (2004) 39(1):99-105.
   PubMed Web of Science ®Google Scholar
• TIDWELL RR, JONES SK, NAIMAN NA et al.: Activity of cationically substituted bisbenzimidazoles against experimental Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. (1993) 37:1713-1716.
   PubMed Web of Science ®Google Scholar
• BOYKIN DW, KUMAR A, XIAO G et al.: 2,5-Bis[4-(N-alkylamidino) phenyl] furans as anti-Pneumocystis carinii agents. J. Med. Chem. (1998) 41:124-129.
   PubMed Web of Science ®Google Scholar
• CROFT SL, BRAZIL RP: Effect of pentamidine isethionate on the ultrastructure and morphology of Leishmania mexicana amazonensis in vitro. Ann. Trop. Med. Parasitol. (1982) 76:37-43.
   PubMed Web of Science ®Google Scholar
• FUSAI T, BOULARD Y, DURAND R et al.: Ultrastructural changes in parasites induced by nanoparticle-bound pentamidine in a Leishmania major/mouse model. Parasite (1997) 4(2):133-139.
   PubMed Web of Science ®Google Scholar
• MESA-VALLE CM, RODRIGUES CABEZAS MN, MORALEDA-LINDE ZV, CRACIUNESCU D, SANCHEZMORENO M, OSUNA A: In vitro and in vivo activity of two Pt (IV) salts against Leishmania donovani. Int. J. Exp. Clin. Pharmcol. (1998) 57(3):160-172.
   Google Scholar
• SILVA CF; MEUSER MB, DE SOUZA EM et al.: Cellular Effects of Reversed Amidines on Trypanosoma cruzi. (2007b) submmited.
   Google Scholar
• MATHIS AM, HOLMAN JL, STURK LM et al.: Accumulation and intracellular distribution of antitrypanosomal diamidine compounds DB75 and DB820 in African trypanosomes. Antimicrob. Agents Chemother. (2006) 50:2185-2191.
   PubMed Web of Science ®Google Scholar
• DYKSTRA CC, TIDWELL RR: Inhibition of topoisomerases from Pneumocystis carinii by aromatic dicationic molecules. J. Protozool. (1991) 38(6):S78-S81.
   PubMedGoogle Scholar
• MORTY RE, TROEBERG L, PIKE RN et al.: A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazene and suramin. FEBS Lett. (1998) 433(3):251-256.
   PubMed Web of Science ®Google Scholar
• JEAN-MORENO V, ROJAS R, GOYENECHE D, COOMBS GH, WALKER J: Leishmania donovani: differential activities of classical topoisomerase inhibitors and antileishmanials against parasite and host cells at the level of DNA topoisomerase I and in cytotoxicity assays. Exp. Parasitol. (2006) 112(1):21-30.
   PubMed Web of Science ®Google Scholar
• DAMPER D, PATTON CL: Pentamidine transport in Trypanosoma brucei-kinetics and specificity. Biochem. Pharmacol. (1976) 25(3):271-276.
   PubMed Web of Science ®Google Scholar
• CARTER NS, BERGER BJ, FAIRLAMB AH: Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei. J. Biol. Chem. (1995) 270(47):28153-28157.
   PubMed Web of Science ®Google Scholar
• BASSELIN M, LAWRENCE F, ROBERT-GERO M: Pentamidine uptake in Leishmania donovani and Leishmania amazonensis promastigotes and axenic amastigotes. Biochem. J. (1996) 315:631-634.
   PubMed Web of Science ®Google Scholar
• MASER P, LUSCHER A, KAMINSKY R: Drug transport and drug resistance in African trypanosomes. Drug Resist. Updat. (2003) 6(5):281-290.
   PubMed Web of Science ®Google Scholar
• BRAY PG, BARRETT MP, WARD SA, DE KONING HP: Pentamidine uptake and resistance in pathogenic protozoa: past, present and future. Trends Parasitol. (2003) 19:232-239.
   PubMed Web of Science ®Google Scholar
• LANTERI CA, STEWART ML, BROCK JM et al.: Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance. Mol. Pharmacol. (2006) 70(5):1585-1592.
   PubMed Web of Science ®Google Scholar
• CARTER NS, BARRETT MP, DE KONING HP: A drug resistance determinant in Trypanosoma brucei. Trends Microbiol. (1999) 7(12):469-471.
   PubMed Web of Science ®Google Scholar
• DE KONING HP: Uptake of pentamidine in Trypanosoma brucei brucei is mediated by three distinct transporters: implications for cross-resistance with arsenicals. Mol. Pharmacol. (2001) 59(3):586-592.
   PubMed Web of Science ®Google Scholar
• BARRETT MP, FAIRLAMB AH: The biochemical basis of arsenical-diamidine cross-resistance in African trypanosomes. Parasitol. Today (1999) 15(4):136-140.
   PubMedGoogle Scholar
• FAIRLAMB AH, CARTER NS, CUNNINGHAM M, SMITH K: Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism. Mol. Biochem. Parasitol. (1992) 53(1-2):213-222.
   PubMed Web of Science ®Google Scholar
• BRIDGES DJ, GOULD MK, NERIMA B, MASER P, BURCHMORE RJ, DE KONING HP: Loss of the high-affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamidine drugs in african trypanosomes. Mol. Pharmacol. (2007) 71(4):1098-1108.
   PubMed Web of Science ®Google Scholar
• BASSELIN M, DENISE H, COOMBS GH, BARRETT MP: Resistence to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion. Antimicrob. Agents Chem. (2002) 46(12):3731-3738.
   PubMed Web of Science ®Google Scholar
• COELHO AC, YAMASHIRO-KANASHIRO EH, BASTOS SF, MORTARA RA, COTRIM PC: Intracellular location of the ABC transporter PRP1 related to pentamidine resistance in Leishmania major. Mol Biochem Parasitol. (2006) 150(2):378-383.
   PubMedGoogle Scholar
• STEAD AMW, BRAY PG, EDWARDS IG et al.: Diamidine compounds: novel antimalarials with two levels of selectivity against Plasmodium falciparum. Mol. Pharmacol. (2001) 59:1298-1306.
   PubMedGoogle Scholar
• ROUSSEL M, NACHER M, FREMONT G et al.: Comparison between one and two injections of pentamidine isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana. Ann. Trop. Med. Parasitol. (2006) 100(4):307-314.
   PubMed Web of Science ®Google Scholar
• EPERON G, SCHMID C, LOUTAN L, CHAPPUIS F: Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children. Acta. Trop. (2007) 101(1):31-39.
   PubMedGoogle Scholar
• ROBLEDO SM, PUERTA JA, MUNOZ DL, GUARDO M, VELEZ ID: Efficacy and tolerance of pentamidine for treatment of cutaneous leishmaniasis caused by por L. (V) panamensis in Colombia. Biomedica (2006) 26(1):188-193.
   PubMedGoogle Scholar
• BECKER I, VOLKOW P, VELASCOCASTREJON O et al.: The efficacy of pentamidine combined with allopurinoland immunotherapy for the treatment of patients with diffuse cutaneous leishmaniasis. Parasitol. Res. (1999) 85(3):165-170.
   PubMedGoogle Scholar
• GLIKSON M, DRESNER-FEIGIN R, POLLACK A, WOLF D, GALUN E, KASPA RT: Pentamidine-induced cardiotoxicity. Isr. J. Med. Sci. (1990) 26(10):588-589.
   PubMedGoogle Scholar
• COYLE P, CARR AD, DEPCZYNSKI BB, CHISHOLM DJ: Diabetes mellitus associated with pentamidine use in HIV-infected patients. Med. J. Aust. (1996) 165(10):587-588.
   PubMed Web of Science ®Google Scholar
• KURYSHEV YA, FICKER E, WANG L et al.: Pentamidine-induced long QT syndrome and block of hERG trafficking. J. Pharm. Exp. Therap. (2005) 312(1):316-323.
   PubMed Web of Science ®Google Scholar
• MILLIGAN KS, PHILLIPS DL: Perioral numbness associated with intravenous pentamidine administration. Ann. Pharmacother. (2007) 41(1):153-156.
   PubMedGoogle Scholar
• BOUTEILLE B, OUKEM O, BISSER S, DUMAS M: Treatment perspectives for human African trypanosomiasis. Fundam. Clin. Pharmacol. (2003) 17:171-181.
   PubMed Web of Science ®Google Scholar
• YERAMIAN P, MESHNICK SR, KRUDSOOD S et al.: Efficacy of DB289 in Thai patients with Plasmodium vivax or acute, uncomplicated Plasmodium falciparum infections. J. Infect. Dis. (2005) 192(2):319-322.
   PubMed Web of Science ®Google Scholar
• STURK LM, BROCK JL, BAGNELL CR, HALL JE, TIDWELL RR: Distribution and quantitation of the anti-trypanosomal diamidine 2,5-bis(4-amidinophenyl) furan (DB75) and its N-methoxy prodrug DB289 in murine brain tissue. Acta. Trop. (2004) 91(2):131-143.
   PubMed Web of Science ®Google Scholar
• MIDGLEY I, FITZPATRICK K, TAYLOR LM et al.: Pharmacokinetics and metabolism of the prodrug DB289 in rat and monkey and its conversion to the antiprotozoal/antifungal drugs DB75. Drug Metab. Dispos. (2007) 35(6):955-967.
   PubMed Web of Science ®Google Scholar
• DOUA F, MIEZAN TW, SANON SINGARO JR, BOA YAPO F, BALTZ T: The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis. Am. J. Trop. Med. Hyg. (1996) 55(6):586-588.
   PubMed Web of Science ®Google Scholar
• DO CAMPO R, MORENO SN: Current chemotherapy of human African trypanosomiasis. Parasitol. Res. (2003) 90(1):10-13.
   Google Scholar
• DONKOR IO, HUANG TL, TAO B et al.: Trypanocidal activity of conformationally restricted pentamidine congeners. J. Med. Chem. (2003) 46(6):1041-1048.
   PubMed Web of Science ®Google Scholar
• DARDONVILLE C, BRUN R: Bisguanidine, bi(2-aminoimidazoline), and polyamine derivatives as potent and selective chemotherapeutic agents against Trypanosoma brucei rhodesiense. J. Med. Chem. (2004) 47:2296-2307.
   PubMed Web of Science ®Google Scholar
• ISMAIL MA, BRUN R, EASTERBROOK JD, TANIOUS FA, WILSON WD, BOYKIN DW: Synthesis and antiprotozoal activity of aza-analogues of furamidine. J. Med. Chem. (2003) 46(22):4761-4769.
   PubMed Web of Science ®Google Scholar
• ANSEDE JH, ANBAZHAGAN M, BRUN R, EASTERBROOK JD, HALL JE, BOYKIN DW: O-alkoxyamidine prodrugs of furamidine: in vitro transport and microsomal metabolism as indicators of in vivo efficacy in a mouse model of Trypanosoma brucei rhodesiense infection. J. Med. Chem. (2004) 47(17):4335-4338.
   PubMed Web of Science ®Google Scholar
• CHACKAL-CATOEN S, MIAO Y, WILSON WD, WENZLER T, BRUN R, BOYKIN DW: Dicationic DNA-targeted antiprotozoal agents: naphthalene replacement of benzimidazole. Bioorg. Med. Chem. (2006) 14(22):7434-7445.
   PubMedGoogle Scholar
• ISMAIL MA, BATISTA-PARRA A, MIAO Y et al.: Dicationic near-linear biphenyl benzimidazole derivatives as DNA-targeted antiprotozoal agents. Bioorg. Med. Chem. (2005) 13(24):6718-6726.
   PubMed Web of Science ®Google Scholar
• GONZALEZ JL, STEPHENS CE, WENZLER T et al.: Synthesis and antiparasitic evaluation of bis-2,5[4-guanidinophenyl]thiophenes. Eur. J. Med. Chem. (2007) (In Press).
   Google Scholar
• ISMAIL MA, ARAFA RK, BRUN R et al.: Synthesis, DNA affinity, and antiprotozoal activity of linear dications: Terphenyl diamidines and analogues J. Med. Chem. (2006) 49(17):5324-5332.
   PubMed Web of Science ®Google Scholar
• CUNHA-NETO E, BILATE AM, HYLAND KV, FONSECA SG, KALIL J, ENGMAN DM: Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity (2006) 39(1):41-54.
   PubMed Web of Science ®Google Scholar
• MARIN NETO JA, SIMOES MV, SARABANDA AV: Chagas' heart disease. Arq. Bras. Cardiol. (1999) 72(3):247-280.
   PubMedGoogle Scholar
• SALLES GF, CARDOSO CR, XAVIER SS, SOUSA AS, HASSLOCHER-MORENO A: Electrocardiographic ventricular repolarization parameters in chronic Chagas' disease as predictors of asymptomatic left ventricular systolic dysfunction. Pacing. Clin. Electrophysiol. (2003) 26(6):1326-1335.
   PubMedGoogle Scholar
• COURA RJ, DE CASTRO SL: A critical review on Chagas' disease chemotherapy. Mem. Inst. Oswaldo Cruz (2002) 97:3-24.
   PubMed Web of Science ®Google Scholar
• URBINA JA: Chemotherapy of Chagas disease. Curr. Pharm. Des. (2002) 8:287-295.
   PubMed Web of Science ®Google Scholar
• STEPHENS CE, TANIOUS F, KIM S et al.: Diguanidino and “reversed” diamidino 2,5-diarylfurans as antimicrobial agents. J. Med. Chem. (2001) 44:1741-1748.
   PubMed Web of Science ®Google Scholar
• STEPHENS CE, BRUN R, SALEM MM et al.: The activity of diguanidino and ‘reversed’ diamidino 2,5-diarylfurans versus Trypanosoma cruzi and Leishmania donovani. Bioorg. Med. Chem. Lett. (2003) 13(12):2065-2069.
   PubMed Web of Science ®Google Scholar
• CUNNINGHAM AC: Parasitic adaptive mechanisms in infection by Leishmania. Exp. Mol. Pathol. (2002) 72(2):132-141.
   PubMed Web of Science ®Google Scholar
• WHO – The World Health Report 2002. World Health Organization (2002).
   Google Scholar
• SUNDAR S, CHATTERJEE M: Visceral leishmaniasis – current therapeutic modalities. Indian J. Med. Res. (2006) 123(3):345-352.
   PubMed Web of Science ®Google Scholar
• OUELLETTE M, DRUMMELSMITH J, PAPADOPOULOU B: Leishmaniasis: drugs in the clinic, resistance and new developments. Drug Resist. Updat. (2004) 7(4-5):257-266.
   PubMed Web of Science ®Google Scholar
• TEMPORAL RM, CYSNE-FINKELSTEIN L, ECHEVARRIA A et al.: Effects of amidine derivatives on parasite-macrophage interaction and evaluation of toxicity. Arzneimittel forschung (2002) 52(6):489-493.
   PubMed Web of Science ®Google Scholar
• BRENDLE JJ, OUTLAW A, KUMAR A et al.: Antileishmanial activities of several classes of aromatic dications. Antimicrob. Agents Chemother. (2002) 46:797-807.
   PubMed Web of Science ®Google Scholar
• MBONGO N, LOISEAU PM, LAWRENCE F, BORIES C, CRACIUNESCU DG, ROBERT-GERO M: In vitro sensitivity of Leishmania donovani to organometallic derivatives of pentamidine. Parasitol. Res. (1997) 83 (5):515-517.
   PubMed Web of Science ®Google Scholar
• MBONGO N, LOISEAU PM, CRACIUNESCU DG, ROBERT-GERO M: Synergistic effect ofIr-(COT)-pentamidine alizarin red and pentamidine, amphotericin B, and paromomycin on Leishmania donovani. Acta Trop. (1998) 70(2):239-245.
   PubMed Web of Science ®Google Scholar
• BANERJEE G, NANDI G, MAHATO SB, PAKRASHI A, BASU MK: Drug delivery system: targeting of pentamidines to specific sites using sugar grafted liposomes. J. Antimicrob. Chemother. (1996) 38(1):145-150.
   PubMed Web of Science ®Google Scholar
• HUANG TL, VANDEN EYNDE JJ, MAYENCE A, DONKOR IO, KHAN SI, TEKWANI BL: Antiplasmodial and anti-leishmanial activity of conformationally restricted pentamidine congeners. J. Pharm. Pharmacol. (2006) 58(8):1033-1042.
   PubMedGoogle Scholar
• PETERSEN E: Malaria chemoprophylaxis: when should we use it and what are the options? Expert Rev. Anti. Infect. Ther. (2004) 2(1):119-132.
   PubMedGoogle Scholar
• HEISCHKEIL R: Effectiveness of trypanocides berenil and pentamidine in rodent malaria (Plasmodium vinckei). Z. Tropenmed. Parasitol. (1971) 22(3):243-249.
   PubMedGoogle Scholar
• DAS BP, BOYKIN DW: Synthesis and antiprotozoal activity of 2,5-bis(4-guanyl-phenyl) thiophenes and pyrroles. J. Med. Chem. (1977) 20:1219-1222.
   PubMed Web of Science ®Google Scholar
• BELL CA, HALL JE, KYLE DE et al.: Structure–activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis. Antimicrob. Agents Chemother. (1990) 34(7):1381-1386.
   PubMed Web of Science ®Google Scholar
• ISMAIL MA, BRUN R, WENZLER T, TANIOUS FA, WILSON WD, BOYKIN DW: Dicationic biphenyl benzimidazole derivatives as antiprotozoal agents. Bioorg. Med. Chem. (2004) 47(14):3658-3664.
   Google Scholar
• MAYENCE A, EYNDE JJV, LE COUR JL, WALKER LA, TEKWANI BL, HUANG TL: Piperazine-linked bisbenzamidines: a novel class of antileishmanial agents. Eur. J. Med. Chem. (2004b) 39:547-553.
   PubMed Web of Science ®Google Scholar
• BRUN R, BALMER O: New developments in human African trypanosomiasis. Curr. Opin. Infect. Dis. (2006) 19(5):415-420.
   PubMedGoogle Scholar